India’s central drug regulator, the Drugs Controller General of India, has reportedly served a notice on a major FMCG company in India to explain why action should not be taken against it for making a misleading claim that its hand sanitizer is a “immunity booster” and that it “kills inactive coronavirus”. This points to an increasing trend amongst FMCG Companies who are making COVID-19 or corona virus related claims to capture the hygiene market. The basis for these claims are various World Health Organization (WHO) and scientific reports that have found that ethyl alcohol or isopropyl alcohol is effective in killing the viruses of corona virus family (including SARS-CoV-2) when used over a certain concentration. However, these tests are done in strict laboratory condition and the viruses are exposed to the active ingredients over a period of time to yield result, which does not typically happen in everyday usage of the product. More importantly, it may not be proper to “logically” extend the findings of external scientific reports to any formulation that carries the same active ingredient as the laboratory drug, for the simple reason that in the event of an inquiry, it will be almost impossible for a company to actually test its product for “immunity” or “killing” properties against corona viruses as these viruses are not available in private labs for testing and are generally considered as health and environmental hazards. Therefore, a very clear assessment of risks versus benefit must be done before making a COVID-19 or corona virus related claim for a formulation. In fact, India’s regulator for alternative systems of medicine (Ministry of AYUSH) has expressly prohibited advertisement for COVID-19 treatment by alternative system of medicines (such as Ayurveda and Homeopathy). And, as such, even for making claims such as “kills upto 99.99% germs”, a company must first check whether its formulation is able to satisfy the claim by testing its formulation in a recognized laboratory as per prescribed international standards
Stay updated about latest legal and regulatory developments in the area of health by subscribing to our newsletter
Pharma
- Bio-pharma
- Specialty Products
- Formulations
- API & Intermediates
- Narcotic and Psychotropic Substances
- Research, Development & Testing
- Pharmacovigilance
Medical Device
- Med-tech
- Implants
- Wearables
- Equipment
- Disposables
- Materiovigilance
Hospitals & Nursing Homes
- Hospitals & Nursing Homes
- Home-care
- Biomedical waste disposal
- Privacy & Data Protection
- Electronic Health Records
Diagnostics
- Reagents
- Diagnostic equipments
- Pathalogy Labs
- Precision Diagnostics
Food & Beverages
- Packaged Food
- Packaged Beverages
- Alcohols & Spirits
- Health Supplements
- Nutraceuticals
- Genetically Modified Food
- Organic Food
Cosmetics
- Haircare
- Skincare
- Oral care
- Fragrances
- Cosmoceuticals
Clinical Trials
- Clinical Trials
- BA/BE studies
- Animal Trials
- CROs
- SMOs
- Post Marketing Surveillance
Emerging Technology
- e-Consultations
- e-Pharmacy
- Drones
- Artificial Intelligence
- Block-chain
- Patient Registry for
- Implants
Insurance
- Get insured
- Get insurance coverage
- for product
Medical Practitioners
- Doctors
- Dentists
- Pharmacists
Classical Medicines
- Ayurveda
- Homeopathy
- Naturopathy
- Ayurceuticals
If you wish to receive more such legal guides and latest updates in your inbox, you can subscribe to our newsletter.